Author:
Fuchs Hendrik,Bachran Christopher,Li Tongyu,Heisler Iring,Dürkop Horst,Sutherland Mark
Reference32 articles.
1. Recombinant immunotoxins for treating cancer;FitzGerald;Int. J. Med. Microbiol.,2004
2. Recombinant antibody fragments and immunotoxin fusions for cancer therapy;Brinkmann;In Vivo,2000
3. In vitro and in vivo cytotoxic activities of recombinant immunotoxin 8H9(Fv)-PE38 against breast cancer, osteosarcoma, and neuroblastoma;Onda;Cancer Res.,2004
4. Mesothelin: a new target for immunotherapy;Hassan;Clin. Cancer Res.,2004
5. Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2;LeMaistre;Blood,1998
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献